These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 34304566)
21. Intense Red-Emitting Upconversion Nanophosphors (800 nm-Driven) with a Core/Double-Shell Structure for Dual-Modal Upconversion Luminescence and Magnetic Resonance in Vivo Imaging Applications. Hong AR; Kim Y; Lee TS; Kim S; Lee K; Kim G; Jang HS ACS Appl Mater Interfaces; 2018 Apr; 10(15):12331-12340. PubMed ID: 29546978 [TBL] [Abstract][Full Text] [Related]
22. Recent Advances in Upconversion Nanoparticles-Based Multifunctional Nanocomposites for Combined Cancer Therapy. Tian G; Zhang X; Gu Z; Zhao Y Adv Mater; 2015 Dec; 27(47):7692-712. PubMed ID: 26505885 [TBL] [Abstract][Full Text] [Related]
23. Combating Concentration Quenching in Upconversion Nanoparticles. Chen B; Wang F Acc Chem Res; 2020 Feb; 53(2):358-367. PubMed ID: 31633900 [TBL] [Abstract][Full Text] [Related]
24. Advancements and applications of upconversion nanoparticles in wound dressings. Gültekin HE; Yaşayan G; Bal-Öztürk A; Bigham A; Simchi AA; Zarepour A; Iravani S; Zarrabi A Mater Horiz; 2024 Jan; 11(2):363-387. PubMed ID: 37955196 [TBL] [Abstract][Full Text] [Related]
25. Upconversion nanoparticles: from hydrophobic to hydrophilic surfaces. Muhr V; Wilhelm S; Hirsch T; Wolfbeis OS Acc Chem Res; 2014 Dec; 47(12):3481-93. PubMed ID: 25347798 [TBL] [Abstract][Full Text] [Related]
26. TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance. Tian G; Zheng X; Zhang X; Yin W; Yu J; Wang D; Zhang Z; Yang X; Gu Z; Zhao Y Biomaterials; 2015 Feb; 40():107-16. PubMed ID: 25433607 [TBL] [Abstract][Full Text] [Related]
27. Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs. Tian G; Yin W; Jin J; Zhang X; Xing G; Li S; Gu Z; Zhao Y J Mater Chem B; 2014 Mar; 2(10):1379-1389. PubMed ID: 32261453 [TBL] [Abstract][Full Text] [Related]
28. Deep-penetrating photodynamic therapy with KillerRed mediated by upconversion nanoparticles. Liang L; Lu Y; Zhang R; Care A; Ortega TA; Deyev SM; Qian Y; Zvyagin AV Acta Biomater; 2017 Mar; 51():461-470. PubMed ID: 28063989 [TBL] [Abstract][Full Text] [Related]
29. Seeing, Targeting and Delivering with Upconverting Nanoparticles. Jalani G; Tam V; Vetrone F; Cerruti M J Am Chem Soc; 2018 Sep; 140(35):10923-10931. PubMed ID: 30113851 [TBL] [Abstract][Full Text] [Related]
30. Immunolabeling and NIR-excited fluorescent imaging of HeLa cells by using NaYF(4):Yb,Er upconversion nanoparticles. Wang M; Mi CC; Wang WX; Liu CH; Wu YF; Xu ZR; Mao CB; Xu SK ACS Nano; 2009 Jun; 3(6):1580-6. PubMed ID: 19476317 [TBL] [Abstract][Full Text] [Related]
31. Near-infrared light triggered photodynamic therapy in combination with gene therapy using upconversion nanoparticles for effective cancer cell killing. Wang X; Liu K; Yang G; Cheng L; He L; Liu Y; Li Y; Guo L; Liu Z Nanoscale; 2014 Aug; 6(15):9198-205. PubMed ID: 24980695 [TBL] [Abstract][Full Text] [Related]
32. Controlled siRNA Release of Nanopolyplex for Effective Targeted Anticancer Therapy in Animal Model. Jia J; Yang J; Qian L; Zhou B; Tang X; Liu S; Wu L; Chen J; Kuang Y Int J Nanomedicine; 2024; 19():1145-1161. PubMed ID: 38344438 [TBL] [Abstract][Full Text] [Related]
33. Emerging NIR light-responsive delivery systems based on lanthanide-doped upconverting nanoparticles. Le XT; Youn YS Arch Pharm Res; 2020 Jan; 43(1):134-152. PubMed ID: 31981073 [TBL] [Abstract][Full Text] [Related]
34. Multicolor tunability and upconversion enhancement of fluoride nanoparticles by oxygen dopant. Niu W; Wu S; Zhang S; Su LT; Tok AI Nanoscale; 2013 Sep; 5(17):8164-71. PubMed ID: 23887282 [TBL] [Abstract][Full Text] [Related]
36. Multifunctional BaYbF Li X; Yi Z; Xue Z; Zeng S; Liu H Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():510-516. PubMed ID: 28415493 [TBL] [Abstract][Full Text] [Related]
37. Dispersion stability and biocompatibility of four ligand-exchanged NaYF Chen Y; D'Amario C; Gee A; Duong HTT; Shimoni O; Valenzuela SM Acta Biomater; 2020 Jan; 102():384-393. PubMed ID: 31794872 [TBL] [Abstract][Full Text] [Related]
38. Near-Infrared-Triggered Upconverting Nanoparticles for Biomedicine Applications. Mahata MK; De R; Lee KT Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34210059 [TBL] [Abstract][Full Text] [Related]
39. 808 nm photocontrolled UCL imaging guided chemo/photothermal synergistic therapy with single UCNPs-CuS@PAA nanocomposite. Liu B; Li C; Xie Z; Hou Z; Cheng Z; Jin D; Lin J Dalton Trans; 2016 Aug; 45(33):13061-9. PubMed ID: 27529086 [TBL] [Abstract][Full Text] [Related]